New personalized therapeutics partner joins Repositive Cancer Model network
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Collaboration agreement to market AZOVA COVID-19 test collection kit online
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Focusing on innate immunity opens way for precision medicine approaches to AD
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing